Impact of COVID-19 morbimortality of oncological patients in Teresina-PI




Impact; Cancer; COVID-19.


The high mortality rate of covid-19 6.7% worldwide, (Turaga & Girotra, 2020), associated with a high transmissibility rate, requires a more targeted study for a portion of the population, which is within the comorbidities, which are cancer patients. Objectives: To verify changes in the hospitalization rates of cancer patients, and the influence of COVID-19 on the death of cancer patients. Methodology: Retrospective study that consists of analyzing the hospitalization and mortality rate of cancer patients between April 2019 and April 2021, through analysis of data available in open databases such as Opendatasus, datasus and the website of the health department of the state of Piauí. The present study has a cross-sectional statistical analysis, which obtained a P<0.0001 through the application of the binomial test, representing a relevance of 99.99%, which included patients with a previous diagnosis of cancer, cancer patients concomitantly diagnosed with COVID -19 through RT-PC; of any sex, age, with a previous diagnosis of cancer who were hospitalized or died, within a period of 2 years (2019-2020 and 2020-2021) in Teresina-PI. Results: A significant decline in hospitalization and mortality of cancer patients was observed over the period 2020-2021.


Emanuel, E. J., Persad, G., Upshur, R., Thome, B., Parker, M., Glickman, A., Zhang, C., Boyle, C., Smith, M., & Phillips, J. P. (2020). Fair Allocation of Scarce Medical Resources in the Time of Covid-19. New England Journal of Medicine, 382(21).

Turaga, K. K., & Girotra, S. (2020). Are We Harming Cancer Patients by Delaying Their Cancer Surgery During the COVID-19 Pandemic? Annals of Surgery, Publish Ahead of Print.

Abikoye, T. M. (2020). Collateral damage: the impact of the COVID-19 pandemic on the care of a patient with tuberculous neuroretinitis in Lagos, Nigeria. Pan African Medical Journal, 35.

Dantas Ferreira, J., Da Silva de Lima, F. C., Pinto Oliveira, J. F., De Camargo Cancela, M., & De Oliveira Santos, M. (2020). Covid-19 e Câncer: Atualização de Aspectos Epidemiológicos. Revista Brasileira de Cancerologia, 66(TemaAtual).

Oncology, T. L. (2020). COVID-19: global consequences for oncology. The Lancet Oncology, 21(4), 467.

Passos, H., Alves, M., Baumworcel, L., Paulo, J., Vieira, C., Dantas, J., Garcez, S., Carlos, A., Sousa, S., São, H., & Rede D'or, L. (n.d.). Relato de Caso Palavras-chave.

Al-Shamsi, H. O., Alhazzani, W., Alhuraiji, A., Coomes, E. A., Chemaly, R. F., Almuhanna, M., Wolff, R., Nuhad, I. K., Chua, M. L. K., Hotte, S. J., Meyers, B. M., Elfiki, T., Curigliano, G., Eng, C., Grothey, A., & Xie, C. (2020). A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group. The Oncologist.

Dai, M., Liu, D., Liu, M., Zhou, F., Li, G., Chen, Z., Zhang, Z., You, H., Wu, M., Zheng, Q., Xiong, Y., Xiong, H., Wang, C., Chen, C., Xiong, F., Zhang, Y., Peng, Y., Ge, S., Zhen, B., & Yu, T. (2020). Patients with cancer appear more vulnerable to SARS-COV-2: a multi-center study during the COVID-19 outbreak. Cancer Discovery, CD–4200422.

Raymond, E., Thieblemont, C., Alran, S., & Faivre, S. (2020). Impact of the COVID-19 Outbreak on the Management of Patients with Cancer. Targeted Oncology, 15(3), 249–259.

Jindal, V., Sahu, K. K., Gaikazian, S., Siddiqui, A. D., & Jaiyesimi, I. (2020). Cancer treatment during COVID-19 pandemic. Medical Oncology, 37(7).

Robilotti, E. V., Babady, N. E., Mead, P. A., Rolling, T., Perez-Johnston, R., Bernardes, M., Bogler, Y., Caldararo, M., Ortiz, C. J. F., Glickman, M. S., Joanow, A., Kaltsas, A., Lee, Y. J., Bianchi, A. L., Mariano, A., Morjaria, S., Nawar, T., Papanicolaou, G. A., Predmore, J., & Redelman-Sidi, G. (2020). Determinants of Severity in Cancer Patients with COVID-19 Illness. Nature Medicine, 26(8), 1218–1223.

Lee, L. Y., Cazier, J.-B., Angelis, V., Arnold, R., Bisht, V., Campton, N. A., Chackathayil, J., Cheng, V. W., Curley, H. M., Fittall, M. W., Freeman-Mills, L., Gennatas, S., Goel, A., Hartley, S., Hughes, D. J., Kerr, D., Lee, A. J., Lee, R. J., McGrath, S. E., & Middleton, C. P. (2020). COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study. The Lancet, 395(10241), 1919–1926.

Jee, J., Foote, M. B., Lumish, M., Stonestrom, A. J., Wills, B., Narendra, V., Avutu, V., Murciano-Goroff, Y. R., Chan, J. E., Derkach, A., Philip, J., Belenkaya, R., Kerpelev, M., Maloy, M., Watson, A., Fong, C., Janjigian, Y., Diaz, L. A., Bolton, K. L., & Pessin, M. S. (2020). Chemotherapy and COVID-19 Outcomes in Patients With Cancer. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 38(30), 3538–3546.

Alcântara, R. C., Silva Junior, L. C. F., Arnozo, G. M., Oliveira, T. F. de, Santana, F. M. S., Silva Filho, E. R. da, Santos, A. G. G. dos, Cunha, E. J. O. da, Aquino, S. H. S. de, Mesquita, R. da R., & Souza, C. D. F. de. (2020). Covid-19 em Pacientes Oncológicos: uma Revisão do Perfil Clínico-Epidemiológico. Revista Brasileira de Cancerologia, 66(TemaAtual).

Carcamo, M., Stumpf, E. R. T., & Mariot, M. P. (2020). Avaliação de servidores em Educação sobre condições de risco para a COVID-19. Revista Thema, 18, 111–123.

Siddiqi, H. K., & Mehra, M. R. (2020). COVID-19 Illness in Native and Immunosuppressed States: A Clinical-Therapeutic Staging Proposal. The Journal of Heart and Lung Transplantation, 39(5).

Saini, K. S., de las Heras, B., de Castro, J., Venkitaraman, R., Poelman, M., Srinivasan, G., Saini, M. L., Verma, S., Leone, M., Aftimos, P., & Curigliano, G. (2020). Effect of the COVID-19 pandemic on cancer treatment and research. The Lancet Haematology.

Araujo SE, Leal A, Centrone AF, Teich VD, Malheiro DT, Cypriano AS, et al. Impacto da COVID-19 sobre o atendimento de pacientes oncológicos: experiência de um centro oncológico localizado em um epicentro Latino-Americano da pandemia. einstein (São Paulo). 2021;19:eAO6282.

Blay, J. Y., Boucher, S., Le Vu, B., Cropet, C., Chabaud, S., Perol, D., Barranger, E., Campone, M., Conroy, T., Coutant, C., De Crevoisier, R., Debreuve-Theresette, A., Delord, J. P., Fumoleau, P., Gentil, J., Gomez, F., Guerin, O., Jaffré, A., Lartigau, E., & Lemoine, C. (2021). Delayed care for patients with newly diagnosed cancer due to COVID-19 and estimated impact on cancer mortality in France. ESMO Open, 6(3), 100134.

Degeling, K., Baxter, N. N., Emery, J., Jenkins, M. A., Franchini, F., Gibbs, P., Mann, G. B., McArthur, G., Solomon, B. J., & IJzerman, M. J. (2021). An inverse stage‐shift model to estimate the excess mortality and health economic impact of delayed access to cancer services due to the COVID‐19 pandemic. Asia-Pacific Journal of Clinical Oncology, 17(4), 359–367.

Gupta, N., Chauhan, A. S., Prinja, S., & Pandey, A. K. (2021). Impact of COVID-19 on Outcomes for Patients With Cervical Cancer in India. JCO Global Oncology, 7, 716–725.



How to Cite

SIQUEIRA, L. N. R. .; CARVALHO FILHO, L. A. de .; RIBEIRO, J. L. V. . Impact of COVID-19 morbimortality of oncological patients in Teresina-PI. Research, Society and Development, [S. l.], v. 11, n. 2, p. e15411225486, 2022. DOI: 10.33448/rsd-v11i2.25486. Disponível em: Acesso em: 22 feb. 2024.



Health Sciences